Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$768M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$625M |
| 3 |
AGN
Allergan plc
AGN
|
+$427M |
| 4 |
McKesson
MCK
|
+$427M |
| 5 |
Johnson Controls International
JCI
|
+$427M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$503M |
| 2 |
RTX Corp
RTX
|
+$457M |
| 3 |
Global Payments
GPN
|
+$441M |
| 4 |
Amazon
AMZN
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$355M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.1% |
| 2 | Healthcare | 3.97% |
| 3 | Industrials | 2.85% |
| 4 | Financials | 2.77% |
| 5 | Consumer Discretionary | 2.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6176
CALL
Encore Capital Group
ECPG
$1.98B
| $533K | ﹤0.01% |
22,800
+4,700
| +26% | +$158K |
|
6177
PUT
Emcor
EME
$36B
| $533K | ﹤0.01% |
+8,700
| New | +$671K |
|
6178
CALL
Ichor Holdings
ICHR
$2.53B
| $533K | ﹤0.01% |
27,800
-14,000
| -33% | -$423K |
|
6179
PUT
Prospect Capital
PSEC
$1.14B
| $532K | ﹤0.01% |
125,200
-556,800
| -82% | -$3.29M |
|
6180
Range Resources
RRC
$9.5B
| $532K | ﹤0.01% |
233,163
+38,246
| +20% | +$122K |
|
|
TPTX
6181
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $532K | ﹤0.01% |
+11,913
| New | +$633K |
|
|
EQC.PRD
6182
DELISTED
Equity Commonwealth 6 1/2% Series D Cumulative Convertible Preferred Shares
EQC.PRD
| $532K | ﹤0.01% |
18,310
+5,165
| +39% | +$144K |
|
6183
PUT
Corcept Therapeutics
CORT
$12.1B
| $531K | ﹤0.01% |
44,700
+19,200
| +75% | +$238K |
|
6184
PUT
Usana Health Sciences
USNA
$254M
| $531K | ﹤0.01% |
9,200
+4,500
| +96% | +$313K |
|
|
LX
6185
LexinFintech Holdings
LX
$242M
| $529K | ﹤0.01% |
59,571
-219,365
| -79% | -$2.71M |
|
6186
New Mountain Finance
NMFC
$730M
| $529K | ﹤0.01% |
77,671
-60,812
| -44% | -$751K |
|
6187
PUT
iShares MSCI South Africa ETF
EZA
$569M
| $528K | ﹤0.01% |
18,600
+5,400
| +41% | +$224K |
|
6188
SLR Investment Corp
SLRC
$706M
| $528K | ﹤0.01% |
45,289
-13,955
| -24% | -$254K |
|
|
SURF
6189
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $528K | ﹤0.01% |
282,130
-1,465
| -0.5% | -$3.86K |
|
6190
PUT
Essent Group
ESNT
$6.08B
| $527K | ﹤0.01% |
20,000
+10,800
| +117% | +$479K |
|
6191
First Trust Latin America AlphaDEX Fund
FLN
$36.1M
| $527K | ﹤0.01% |
+43,664
| New | +$858K |
|
6192
Genmab
GMAB
$19.2B
| $527K | ﹤0.01% |
24,859
-417,900
| -94% | -$9.32M |
|
6193
Banco Santander
SAN
$210B
| $527K | ﹤0.01% |
233,871
-1,443,753
| -86% | -$4.95M |
|
6194
Crinetics Pharmaceuticals
CRNX
$8.95B
| $526K | ﹤0.01% |
35,737
+7,809
| +28% | +$160K |
|
|
BAND
6195
CALL
Bandwidth Inc
BAND
$1.66B
| $525K | ﹤0.01% |
7,800
-3,600
| -32% | -$245K |
|
6196
PUT
Fidelity National Financial
FNF
$12.8B
| $525K | ﹤0.01% |
21,944
+15,912
| +264% | +$625K |
|
6197
CALL
GoPro
GPRO
$107M
| $525K | ﹤0.01% |
200,200
-520,300
| -72% | -$1.93M |
|
6198
PUT
Intellia Therapeutics
NTLA
$1.68B
| $525K | ﹤0.01% |
42,900
-13,000
| -23% | -$175K |
|
6199
Invesco S&P Spin-Off ETF
CSD
$229M
| $524K | ﹤0.01% |
18,405
-10,267
| -36% | -$439K |
|
6200
CALL
Viper Energy
VNOM
$15.4B
| $524K | ﹤0.01% |
79,000
-51,500
| -39% | -$936K |
|
Similar funds
Citadel Advisors's Q1 2020 Portfolio in Review
As of Q1 2020, Citadel Advisors held 10,687 positions worth $222B, down 3.5% from $230B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors deployed $36.9B of net new capital in Q1 2020, opening 1,650 new positions and adding to 4,224 existing holdings. Its largest new stake was Invesco QQQ Trust: 2,950,335 shares worth $562M.
By sector, the portfolio is most concentrated in Technology at 4.1% of assets, down from 5.1% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Uber, an estimated $503M trimmed.
- Citadel Advisors's largest Q1 2020 buy was Invesco QQQ Trust: 2,950,335 shares worth $562M.
- Citadel Advisors added most to Charter Communications in Q1 2020, an estimated $768M increase.
- Citadel Advisors's biggest Q1 2020 reduction was Uber, cutting an estimated $503M.
- Citadel Advisors fully exited Zayo Group Holdings, Inc. in Q1 2020, selling an estimated $280M.
- Citadel Advisors's ten largest holdings make up 32% of its $222B portfolio in Q1 2020.
- Citadel Advisors opened 1,650 new positions and closed 1,165 in Q1 2020.
- Citadel Advisors's portfolio value fell 3.5% quarter-over-quarter to $222B.
Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.